INTERVIEW: Medtech innovation needs in the UK – who is really listening?
This article was originally published in Clinica
Just as NHS England hopes parliamentarians, opinion formers, decision makers, clinicians and patients all buy into the well-argued messages in its Five Year Forward View, the UK medical technology industry hopes its own vital messages about value and adoption are allowed to play into the NHS’s planning for the future.
You may also be interested in...
The MHRA has been working all hours to ensure the standalone medtech UKCA mark works operationally and procedurally in the UK as of 1 January 2021.
Siemens Healthineers' product mix of diagnostics and imaging products meant it was in the middle of a very dynamic situation when COVID-19 struck.
The national regulator is to undergo a review in 2021 as the UK begins life as a former EU member, presenting opportunities to be seized.